Intravenous Magnesium Sulfate for Acute Pain Management After Laparotomy Surgery: A Case Series
Abstract
Introduction: Perioperative pain management is indicated to relieve patient complaints, allow early mobilization after surgery, reduce the duration of hospital stay, and provide a better level of satisfaction. This study aims to describe the use of magnesium sulfate in post-laparotomy patients.
Case presentation: There were two cases, and the first was a 41-year-old female patient with endometrial cysts and adenomyosis who underwent laparotomy under general anesthesia. The patient was given magnesium sulfate 30 mg/kgBW 20 minutes before induction, then a continuous dose via a syringe pump 10 mg/kgBW/hour until the operation was completed. This patient showed an NRS scale 1 hour after surgery 1/10 and after 24 hours a maximum of 3/10. The second case was a 42-year-old female patient with suspected Leimiosarcoma who underwent a total hysterectomy and bilateral salpingoovorectomy under general anesthesia. Patients also received the same administration of magnesium sulfate and were assessed on the NRS scale up to 2 hours postoperatively 1/10 and after 24 hours a maximum of 2/10.
Conclusion: Magnesium sulfate is used as an adjuvant in postoperative analgesia and analgesic therapy to treat acute or chronic pain and has antinociceptive effects due to NMDA receptor blocking, making it useful for the prevention of central sensitization.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.